Literature DB >> 30615014

Early Deaths in Pediatric Acute Leukemia: A Major Challenge in Developing Countries.

Hanafy A Hafez1, Rawaa M Soliaman2, Dalia Bilal3, Mohamed Hashem4, Lobna M Shalaby1.   

Abstract

Children with acute leukemia may experience high treatment-related mortality, which often occurs early in the induction phase. The aim of the study was to assess the incidence and risk factors related to increased mortality during induction therapy of pediatric patients with acute leukemia. This is a retrospective study that included pediatric acute leukemia patients who presented to the National Cancer Institute, Cairo University, between January 2011 and December 2013. The study included 370 patients, 253 with acute lymphoblastic leukemia, 100 with acute myeloid leukemia, and 17 with mixed phenotype acute leukemia. The total and induction death rates were 40.5% and 19.2%, respectively. Most of the early deaths were attributed to infections (64.7%) and cerebrovascular accidents (18.3%). Using enhanced supportive care measures during 2013 had significantly reduced the overall and induction mortality rates (29% and 13.6%, respectively, in 2013 vs. 46% and 20.3% in 2011). Induction deaths in pediatric acute leukemia remain a major challenge in developing countries, and using enhanced supportive care measures is effective to improve the survival outcome in this group of patients.

Entities:  

Year:  2019        PMID: 30615014     DOI: 10.1097/MPH.0000000000001408

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

1.  Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study.

Authors:  Yixin Hu; Aili Chen; Li Gao; Hailong He; Shuting Jiang; Xinchang Zheng; Peifang Xiao; Jun Lu; Yi Wang; Jie Li; Jianqin Li; Junjie Fan; Yanhua Yao; Jing Ling; Liyan Fan; Shengqin Cheng; Cheng Cheng; Fang Fang; Jian Pan; Qian-Fei Wang; Raul C Ribeiro; Shaoyan Hu
Journal:  Blood Adv       Date:  2021-04-13

2.  Frequency of Infectious Mortality at the End of Induction Chemotherapy in Acute Lymphoblastic Leukemia and Lymphoma Patients: Findings From a Tertiary Care Cancer Center.

Authors:  Rabia Wali; Sadia Anjum; Asim Amjad; Najma Shaheen; Saadiya Javed Khan
Journal:  Cureus       Date:  2021-02-07

3.  Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya.

Authors:  Romy E van Weelderen; Festus Njuguna; Kim Klein; Saskia Mostert; Sandra Langat; Terry A Vik; Gilbert Olbara; Martha Kipng'etich; Gertjan J L Kaspers
Journal:  Cancer Rep (Hoboken)       Date:  2021-11-22

4.  Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and Molecular Docking Study.

Authors:  Edgar Márquez; José R Mora; Virginia Flores-Morales; Daniel Insuasty; Luis Calle
Journal:  Molecules       Date:  2019-12-19       Impact factor: 4.411

5.  Childhood cancer mortality trends in the Americas and Australasia: An update to 2017.

Authors:  Matteo Malvezzi; Claudia Santucci; Gianfranco Alicandro; Greta Carioli; Paolo Boffetta; Karina Braga Ribeiro; Fabio Levi; Carlo La Vecchia; Eva Negri; Paola Bertuccio
Journal:  Cancer       Date:  2021-05-27       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.